πŸ‡ΊπŸ‡Έ FDA
Patent

US 6469184

Total synthesis of antitumor acylfulvenes

expired A61PA61P35/00

Quick answer

US patent 6469184 (Total synthesis of antitumor acylfulvenes) held by The Regents of the University of California expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00